Pangenomic Health Inc. (CSE:NARA)
0.650
-0.150 (-18.75%)
At close: Dec 4, 2025
Pangenomic Health Statistics
Total Valuation
CSE:NARA has a market cap or net worth of CAD 16.71 million. The enterprise value is 16.62 million.
| Market Cap | 16.71M |
| Enterprise Value | 16.62M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:NARA has 25.70 million shares outstanding. The number of shares has increased by 247.96% in one year.
| Current Share Class | 25.70M |
| Shares Outstanding | 25.70M |
| Shares Change (YoY) | +247.96% |
| Shares Change (QoQ) | +11.79% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | n/a |
| Float | 25.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -9.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.88 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -85.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,092.22% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 164.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +333.33% in the last 52 weeks. The beta is 0.24, so CSE:NARA's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +333.33% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 0.98 |
| Relative Strength Index (RSI) | 35.45 |
| Average Volume (20 Days) | 18,815 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -745,494 |
| Operating Income | -2.92M |
| Pretax Income | -3.41M |
| Net Income | -3.41M |
| EBITDA | -2.91M |
| EBIT | -2.92M |
| Earnings Per Share (EPS) | -0.26 |
Balance Sheet
The company has 82,164 in cash and n/a in debt, giving a net cash position of 82,164 or 0.00 per share.
| Cash & Cash Equivalents | 82,164 |
| Total Debt | n/a |
| Net Cash | 82,164 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -1.77M |
| Book Value Per Share | -0.07 |
| Working Capital | -1.78M |
Cash Flow
| Operating Cash Flow | -1.70M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:NARA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -247.96% |
| Shareholder Yield | -247.96% |
| Earnings Yield | -20.39% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 14, 2024. It was a reverse split with a ratio of 0.2.
| Last Split Date | Nov 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |